Menopausal hormone therapy and risk of endometrial cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 142, Issue , 2014, Pages 83-89

  Brinton, Louise A ^a   Felix, Ashley S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Endometrial cancer; Epidemiology; Menopausal hormone therapy; Risk

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL PRACTICE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EXPOSURE; DRUG USE; ENDOMETRIUM CANCER; HIGH RISK POPULATION; HORMONAL CARCINOGENESIS; HORMONAL THERAPY; HUMAN; MEDICAL PARAMETERS; MENOPAUSE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PRESCRIPTION; RISK MANAGEMENT; RISK REDUCTION;

ENDOMETRIAL CANCER; EPIDEMIOLOGY; MENOPAUSAL HORMONE THERAPY; RISK;

ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; PROGESTINS;

EID: 84899917635     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.05.001     Document Type: Article

References (58)

1. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, and S.F. Altekruse et al. SEER Cancer Statistics Review, 1975-2009 2011 National Cancer Institute Bethesda, MD 412 http://seer.cancer.gov/csr/1975-2009-pops09 (11.01.11)
2. A. Akhmedkhanov, A. Zeleniuch-Jacquotte, and P. Toniolo Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives Annals of the New York Academy of Sciences 943 2001 296 315
3. T.J. Key, and M.C. Pike The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk British Journal of Cancer 57 2 1988 205 212
4. D.W. Cramer The epidemiology of endometrial and ovarian cancer Hematology/Oncology Clinics of North America 26 1 2012 1 12
5. N.S. Weiss, D.R. Szekely, and D.F. Austin Increasing incidence of endometrial cancer in the United States New England Journal of Medicine 294 23 1976 1259 1262
6. D. Grady, T. Gebretsadik, K. Kerlikowske, V. Ernster, and D. Petitti Hormone replacement therapy and endometrial cancer risk: a meta-analysis Obstetrics and Gynecology 85 2 1995 304 313
7. L.A. Brinton, and R.N. Hoover Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group Obstetrics and Gynecology 81 2 1993 265 271
8. P.K. Green, N.S. Weiss, B. McKnight, L.F. Voigt, and S.A. Beresford Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States) Cancer Causes and Control 7 6 1996 575 580
9. S. Campbell, J. McQueen, J. Minardi, and M.I. Whitehead The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens Postgraduate Medical Journal 54 Suppl. 2 1978 59 64
10. A. Lethaby, J. Suckling, D. Barlow, C.M. Farquhar, R.G. Jepson, and H. Roberts Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding Cochrane Database of Systematic Reviews 3 2004 CD000402
11. M.I. Whitehead, S. Campbell, G. Dyer, W.P. Collins, J. Pryse-Davies, and T.A. Ryder et al. Progestogen modification of endometrial histology in menopasual women British Medical Journal 2 6152 1978 1643 1644
12. M.I. Whitehead, R.J. King, J. McQueen, and S. Campbell Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy Journal of the Royal Society of Medicine 72 5 1979 322 327
13. S. Furness, H. Roberts, J. Marjoribanks, and A. Lethaby Hormone therapy in postmenopausal women and risk of endometrial hyperplasia Cochrane Database of Systematic Reviews 8 2012 CD000402
14. E.J. Crosbie, M. Zwahlen, H.C. Kitchener, M. Egger, and A.G. Renehan Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis Cancer Epidemiology, Biomarkers and Prevention 19 12 2010 3119 3130
15. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 2008 569 578
16. A. Lukanova, E. Lundin, A. Zeleniuch-Jacquotte, P. Muti, A. Mure, and S. Rinaldi et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women European Journal of Endocrinology/European Federation of Endocrine Societies 150 2 2004 161 171
17. V. Beral, D. Bull, and G. Reeves Endometrial cancer and hormone-replacement therapy in the Million Women Study Lancet 365 9470 2005 1543 1551
18. M.G. Jain, T.E. Rohan, and G.R. Howe Hormone replacement therapy and endometrial cancer in Ontario, Canada Journal of Clinical Epidemiology 53 4 2000 385 391
19. S. Karageorgi, S.E. Hankinson, P. Kraft, and V.I. De Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004 International Journal of Cancer 126 1 2010 208 216
20. J.V. Lacey Jr., M.F. Leitzmann, S.C. Chang, T. Mouw, A.R. Hollenbeck, and A. Schatzkin et al. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort Cancer 109 7 2007 1303 1311
21. M.C. Pike, R.K. Peters, W. Cozen, N.M. Probst-Hensch, J.C. Felix, and P.C. Wan et al. Estrogen-progestin replacement therapy and endometrial cancer Journal of the National Cancer Institute 89 15 1997 1110 1116
22. J.V. Lacey Jr., L.A. Brinton, J.H. Lubin, M.E. Sherman, A. Schatzkin, and C. Schairer Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women Cancer Epidemiology, Biomarkers and Prevention 14 7 2005 1724 1731
23. P.A. Newcomb, and A. Trentham-Dietz Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States) Cancer Causes and Control 14 2 2003 195 201
24. P. Razavi, M.C. Pike, P.L. Horn-Ross, C. Templeman, L. Bernstein, and G. Ursin Long-term postmenopausal hormone therapy and endometrial cancer Cancer Epidemiology, Biomarkers and Prevention 19 2 2010 475 483
25. J. Chubak, J.A. Doherty, K.L. Cushing-Haugen, L.F. Voigt, B.S. Saltzman, and D.A. Hill et al. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy Cancer Causes and Control 18 9 2007 1001 1007
26. D.A. Hill, N.S. Weiss, S.A. Beresford, L.F. Voigt, J.R. Daling, and J.L. Stanford et al. Continuous combined hormone replacement therapy and risk of endometrial cancer American Journal of Obstetrics and Gynecology 183 6 2000 1456 1461
27. E. Weiderpass, H.O. Adami, J.A. Baron, C. Magnusson, R. Bergstrom, and A. Lindgren et al. Risk of endometrial cancer following estrogen replacement with and without progestins Journal of the National Cancer Institute 91 13 1999 1131 1137
28. N.E. Allen, K.K. Tsilidis, T.J. Key, L. Dossus, R. Kaaks, and E. Lund et al. Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition American Journal of Epidemiology 172 12 2010 1394 1403
29. S. Jaakkola, H.K. Lyytinen, T. Dyba, O. Ylikorkala, and E. Pukkala Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study International Journal of Cancer 128 7 2011 1644 1651
30. B.L. Strom, R. Schinnar, A.L. Weber, G. Bunin, J.A. Berlin, and M. Baumgarten et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer American Journal of Epidemiology 164 8 2006 775 786
31. B. Trabert, N. Wentzensen, H.P. Yang, M.E. Sherman, A.R. Hollenbeck, and Y. Park et al. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? International Journal of Cancer 132 2 2012 417 426
32. G.L. Anderson, H.L. Judd, A.M. Kaunitz, D.H. Barad, S.A. Beresford, and M. Pettinger et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial JAMA 290 13 2003 1739 1748
33. S. Hulley, C. Furberg, E. Barrett-Connor, J. Cauley, D. Grady, and W. Haskell et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 1 2002 58 66
34. A.I. Phipps, J.A. Doherty, L.F. Voigt, D.A. Hill, S.A. Beresford, and M.A. Rossing et al. Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer Cancer Causes and Control 22 12 2011 1639 1646
35. J.A. Doherty, K.L. Cushing-Haugen, B.S. Saltzman, L.F. Voigt, D.A. Hill, and S.A. Beresford et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer American Journal of Obstetrics and Gynecology 197 2 2007 139 147
36. I. Persson, H.O. Adami, L. Bergkvist, A. Lindgren, B. Pettersson, and R. Hoover et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study BMJ 298 6667 1989 147 151
37. L.M. Newcomer, P.A. Newcomb, A. Trentham-Dietz, and B.E. Storer Hormonal risk factors for endometrial cancer: modification by cigarette smoking (United States) Cancer Causes and Control 12 9 2001 829 835
38. G.L. Rubin, H.B. Peterson, N.C. Lee, E.F. Maes, P.A. Wingo, and S. Becker Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies American Journal of Obstetrics and Gynecology 162 1 1990 148 154
39. M. Jondet, M. Maroni, H. Yaneva, S. Brin, F. Peltier-Pujol, and C. Pelissier Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone Maturitas 41 2 2002 115 121
40. S.D. Reed, L.F. Voigt, S.A. Beresford, D.A. Hill, J.A. Doherty, and N.S. Weiss Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer American Journal of Obstetrics and Gynecology 191 4 2004 1146 1151
41. S. Jaakkola, H. Lyytinen, E. Pukkala, and O. Ylikorkala Endometrial cancer in postmenopausal women using estradiol-progestin therapy Obstetrics and Gynecology 114 6 2009 1197 1204
42. C.S. de Vries, S.E. Bromley, H. Thomas, and R.D. Farmer Tibolone and endometrial cancer: a cohort and nested case-control study in the UK Drug Safety 28 3 2005 241 249
43. R. Yazigi, S. Sahid, L. Contreras, and T. Rodriguez Carcinoma of the endometrium in patients treated with tibolone Gynecologic Oncology 93 2 2004 568 570
44. J.A. Shapiro, N.S. Weiss, S.A. Beresford, and L.F. Voigt Menopausal hormone use and endometrial cancer, by tumor grade and invasion Epidemiology 9 1 1998 99 101
45. J.M. Elwood, and D.A. Boyes Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens Gynecologic Oncology 10 2 1980 173 187
46. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecologic Oncology 15 1 1983 10 17
47. H.P. Yang, N. Wentzensen, B. Trabert, G.L. Gierach, A.S. Felix, and M.J. Gunter et al. Endometrial cancer risk factors by two main histologic subtypes in the NIH-AARP Diet and Health Study American Journal of Epidemiology 177 2 2012 142 151
48. B. Ettinger, I.M. Golditch, and G. Friedman Gynecologic consequences of long-term, unopposed estrogen replacement therapy Maturitas 10 4 1988 271 282
49. F.W. Lafferty, and D.O. Helmuth Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects Maturitas 7 2 1985 147 159
50. A. Paganini-Hill, R.K. Ross, and B.E. Henderson Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study British Journal of Cancer 59 3 1989 445 447
51. D.B. Petitti, J.A. Perlman, and S. Sidney Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study Obstetrics and Gynecology 70 3 Pt 1 1987 289 293
52. S.J. Robboy, and R. Bradley Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy Obstetrics and Gynecology 54 3 1979 269 277
53. J. Collins, A. Donner, L.H. Allen, and O. Adams Oestrogen use and survival in endometrial cancer Lancet 2 8201 1980 961 964
54. C.C. Orgeas, P. Hall, S. Wedren, P.W. Dickman, and K. Czene The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients European Journal of Cancer 45 17 2009 3064 3073
55. D.C. Smith, R.L. Prentice, and D.E. Bauermeister Endometrial carcinoma: histopathology, survival, and exogenous estrogens Gynecologic and Obstetric Investigation 12 4 1981 169 179
56. P.B. Underwood Jr., M.C. Miller, A. Kreutner Jr., C.A. Joyner, and M.H. Lutz Endometrial carcinoma: the effect of estrogens Gynecologic Oncology 8 1 1979 60 73
57. C. Schairer, H.O. Adami, R. Hoover, and I. Persson Cause-specific mortality in women receiving hormone replacement therapy Epidemiology 8 1 1997 59 65
58. J.A. Schwartzbaum, B.S. Hulka, W.C. Fowler Jr., D.G. Kaufman, and D. Hoberman The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer American Journal of Epidemiology 126 5 1987 851 860